Literature DB >> 9403126

Ageing and calcium metabolism.

R Bouillon1, G Carmeliet, S Boonen.   

Abstract

Ageing alters the metabolism of calcium and vitamin D in a number of ways. Intake of calcium and vitamin D, exposure to sunlight, cutaneous production of vitamin D3, renal production of 1,25-dihydroxyvitamin D (1,25(OH)2D3), intestinal absorption of calcium and the ability to adapt to a low calcium diet may all be reduced in elderly subjects. As a consequence, secondary hyperparathyroidism often occurs with ageing and can contribute to accelerated bone loss. In fact, alterations in calcium and vitamin D metabolism may be widespread in the ageing population and play a central role in the pathogenesis of senile (age-related) osteoporosis. From a preventive point of view, recent intervention studies have indicated the need to optimize calcium intake and to maintain serum 25(OH)D3 levels within the normal range in elderly people.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403126     DOI: 10.1016/s0950-351x(97)80332-1

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  8 in total

1.  Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study.

Authors:  Farahnaz Saleh; Rolf Jorde; Johan Sundsfjord; Egil Haug; Yngve Figenschau
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis.

Authors:  L Lieben; B S Benn; D Ajibade; I Stockmans; K Moermans; M A Hediger; J B Peng; S Christakos; R Bouillon; G Carmeliet
Journal:  Bone       Date:  2010-04-24       Impact factor: 4.398

3.  Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study.

Authors:  Rolf Jorde; Knut Waterloo; Farahnaz Saleh; Egil Haug; Johan Svartberg
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

4.  The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3.

Authors:  J Wesley Pike; Mark B Meyer
Journal:  Rheum Dis Clin North Am       Date:  2012-04-12       Impact factor: 2.670

Review 5.  The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3).

Authors:  J Wesley Pike; Mark B Meyer
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

6.  Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.

Authors:  Elizabeth A Streeten; Amy S Rogstad; Kristin M Flammer; Kiarash Zarbalian; Kathleen Ryan; Mara Horwitz; Michael F Holick; John Shelton
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

7.  The Incidence of Severe Hypercalcaemia-Induced Mental Status Changes in Patients Treated with Antibiotic-Loaded Calcium Sulphate Depot for Orthopaedic Infections.

Authors:  Faustine Vallon; Christoph Meier; Emanuel Gautier; Peter Wahl
Journal:  J Clin Med       Date:  2022-08-20       Impact factor: 4.964

8.  Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

Authors:  Audrey Neuprez; Olivier Bruyère; Julien Collette; Jean-Yves Reginster
Journal:  BMC Public Health       Date:  2007-04-26       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.